Cyclic fasting-mimicking diet in cancer treatment: Preclinical and clinical evidence
Cell Metabolism · 2024-08 · 36 (8) · 1644-1667
DOI: 10.1016/j.cmet.2024.06.014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Metabolism, 2024-08. Verfasst von Claudio Vernieri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology and Hematology-Oncology Department, University of Milan, 20122 Milan, Italy; IFOM ETS, the AIRC Institute of Molecular Oncology, 201…. Hauptthemen laut MEDLINE: Fasting, Neoplasms, Diet. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 125 Literaturangaben. Gefördert von: Associazione Italiana per la Ricerca sul Cancro, National Institute on Aging, U.S. Department of Defense.
Abstract (Originalsprache)
In preclinical tumor models, cyclic fasting and fasting-mimicking diets (FMDs) produce antitumor effects that become synergistic when combined with a wide range of standard anticancer treatments while protecting normal tissues from treatment-induced adverse events. More recently, results of phase 1/2 clinical trials showed that cyclic FMD is safe, feasible, and associated with positive metabolic and immunomodulatory effects in patients with different tumor types, thus paving the way for larger clinical trials to investigate FMD anticancer activity in different clinical contexts. Here, we review the tumor-cell-autonomous and immune-system-mediated mechanisms of fasting/FMD antitumor effects, and we critically discuss new metabolic interventions that could synergize with nutrient starvation to boost its anticancer activity and prevent or reverse tumor resistance while minimizing toxicity to patients. Finally, we highlight potential future applications of FMD approaches in combination with standard anticancer strategies as well as strategies to implement the design and conduction of clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Oncology and Hematology-Oncology Department, University of Milan, 20122 Milan, Italy; IFOM ETS, the AIRC Institute of Molecular Oncology, 20139 Milan, Italy. Electronic address: claudio.vernieri@unimi.it.
- Medical Oncology and Hematology-Oncology Department, University of Milan, 20122 Milan, Italy; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
- Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1354, 1515 Holcombe Blvd, Houston, TX 77030-4009, USA.
- IFOM ETS, the AIRC Institute of Molecular Oncology, 20139 Milan, Italy; Longevity Institute, Davis School of Gerontology and Department of Biological Sciences, University of Southern California, Los Angeles, CA 90089, U…
Förderung
- Associazione Italiana per la Ricerca sul Cancro
- National Institute on Aging
- U.S. Department of Defense
- European Research Council
- Fondazione Italiana per la Ricerca sul Cancro
- National Institutes of Health
Zitieren
APA
Vernieri, C., Ligorio, F., Tripathy, D., & Longo, V. D. (2024). Cyclic fasting-mimicking diet in cancer treatment: Preclinical and clinical evidence. Cell Metabolism, 36(8), 1644-1667. https://doi.org/10.1016/j.cmet.2024.06.014
Vancouver
Vernieri C, Ligorio F, Tripathy D, Longo VD. Cyclic fasting-mimicking diet in cancer treatment: Preclinical and clinical evidence. Cell Metabolism. 2024;36(8):1644-1667. doi:10.1016/j.cmet.2024.06.014
BibTeX
@article{Vernieri2024,
author = {Vernieri, Claudio and Ligorio, Francesca and Tripathy, Debu and Longo, Valter D},
title = {Cyclic fasting-mimicking diet in cancer treatment: Preclinical and clinical evidence},
journal = {Cell Metabolism},
year = {2024},
volume = {36},
number = {8},
pages = {1644--1667},
doi = {10.1016/j.cmet.2024.06.014}
}
EUVIMED